Facebook
Twitter
LinkedIn
Forward- ASHLEY BARTLETT
Series Overview
This series addresses new and/or developing research, technology, therapy, and practice guidelines in various areas of cardiovascular medicine. Sessions aim to address developments in treating cardiovascular related diseases well as practice issues identified in QA conferences.
Target Audience
Cardiovascular Medicine Faculty (MD, DO), Physicians, Fellows, Residents, Physician Assistants, Nurse Practitioners, Nurses (RN, APRN, LPN), Lab Personnel, Students. Some sessions will be relevant to Internal Medicine, Cardiothoracic Surgery and Pediatric Cardiology.
Planning Committee
| Peter Rahko, MD, Chair | Ashley Bartlett, RSS Coordinator | Zachary D. Goldberger, MD |
Accreditation
Accreditation Statement
 | In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. |
Credit Designation Statements
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Education Units
The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.1 continuing education units (CEUs) or 1 hour.
POLICY ON FACULTY AND SPONSOR DISCLOSURE
It is the policy of the University of Wisconsin–Madison ICEP, that the faculty, authors, planners, and other persons who may influence content of this CE activity disclose all relevant financial relationships with commercial interests in order to allow CE staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s).
Detailed disclosures will be available prior to the start of the activity.
After participation in this regularly scheduled series, participants will:
- Improve their ability to provide state of the art, patient-centered cardiovascular care to patients in the clinic, on the inpatient services and in the diagnostic laboratory.
- Improve their practice performance in the areas of diagnostic testing for CV disease, appropriate use of newly released medications, and implementation of guideline-recommended treatment for all forms of CV disease.
- Expand their knowledge about new discoveries in the pathophysiology of cardiovascular disease.